Should public reporting be made for performance indicators on healthcare-associated infections?

被引：5

作者：

Lucet, J. -C. ^{[1
,2
]}

Parneix, P. ^{[3
]}

Grandbastien, B. ^{[4
]}

Berthelot, P. ^{[5
,6
]}

机构：

[1] Hop Bichat Claude Bernard, AP HP, Unite Hyg & Lutte Infect Nosocomiale, F-75018 Paris, France

[2] Univ Paris Diderot, Sorbonne Paris Cite, F-75205 Paris 13, France

[3] CHU Bordeaux, Hop Pellegrin, CClin Sud Ouest, F-33076 Bordeaux, France

[4] CHRU Lille, Hop Calmette, SGRIVi, F-59037 Lille, France

[5] CHU St Etienne, Serv Malad Infect, Unite Hyg Interhosp, F-42055 St Etienne 2, France

[6] CHU St Etienne, Lab Microbiol, F-42055 St Etienne 2, France

来源：

MEDECINE ET MALADIES INFECTIEUSES | 2013年 / 43卷 / 03期

关键词：

Healthcare-associated infection; Nosocomial infection; Indicator; Quality improvement; Public reporting; NOSOCOMIAL INFECTIONS; SURVEILLANCE; QUALITY; NONPAYMENT; IMPACT; ZERO;

D O I：

10.1016/j.medmal.2013.03.002

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

There are still many uncertainties regarding the benefit of public reporting on indicators of healthcare-associated infections. Publishing the results of performance indicators in healthcare facilities seems to stimulate quality insurance activity, but for the moment, without any demonstrated impact on the rates of healthcare-associated infections. Furthermore, it is not proved that public reporting of these results is beneficial. The French Society for Hospital Hygiene, in this synthesis, considered the advantages and drawbacks of public reporting of healthcare-associated infections. Beyond the difficult choice of indicators, public reporting of such indicators requires taking many precautions listed in this article, including a broad dialogue between the various stakeholders involved, a test period, and mandatory control of the produced indicator validity by health authorities. (c) 2013 Elsevier Masson SAS. All rights reserved.

引用

页码：108 / 113

页数：6

共 50 条

[41] Evaluating Healthcare-Associated Infections in Public Hospitals: A Cross-Sectional Study
Iancu, Daniela
Moldovan, Iuliu
Tilea, Brindusa
Voidazan, Septimiu
ANTIBIOTICS-BASEL, 2023, 12 (12):
[42] Which Comorbid Conditions Should We Be Analyzing as Risk Factors for Healthcare-Associated Infections?
Harris, Anthony D.
Pineles, Lisa
Anderson, Deverick
Woeltje, Keith F.
Trick, William E.
Kaye, Keith S.
Yokoe, Deborah S.
Nyquist, Ann-Christine
Calfee, David P.
Leekha, Surbhi
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (04): : 449 - 454
[43] Consensus standards and performance indicators for prevention and control of healthcare-associated infection in Europe
Cookson, B.
Mackenzie, D.
Coutinho, A. P.
Russell, I.
Fabry, J.
JOURNAL OF HOSPITAL INFECTION, 2011, 79 (03) : 260 - 264
[44] Healthcare-associated bacterial infections in the paediatric ICU
Akinkugbe, Olugbenga
Cooke, Fiona J.
Pathan, Nazima
JAC-ANTIMICROBIAL RESISTANCE, 2020, 2 (03):
[45] Healthcare-associated infections. A useful concept?
Lujan, Manel
Gallego, Miguel
Rello, Jordi
CURRENT OPINION IN CRITICAL CARE, 2009, 15 (05) : 419 - 424
[46] An examination of healthcare-associated infections in elderly patients
Iskender, Serap
Yilmaz, Gurdal
Koksal, Iftihar
TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (06) : 1693 - 1698
[47] Prevention of Healthcare-associated Infections of Oncologic Patients
Ona, Lourdes Elizabeth Menendez
Salazar, Gabriela Alejandra Valbuena
Velasquez, Gerardo Jose Sanchez
MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2024, 22 (06): : 1200 - 1206
[48] Vaccines for Healthcare-associated Infections: Promise and Challenge
Knisely, Jane M.
Liu, Baoying
Ranallo, Ryan T.
Zou, Lanling
CLINICAL INFECTIOUS DISEASES, 2016, 63 (05) : 657 - 662
[49] Network Approach for Prevention of Healthcare-Associated Infections
Horan, Teresa C.
Arnold, Kathryn E.
Rebmann, Catherine A.
Fridkin, Scott K.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (11): : 1143 - 1144
[50] Laying down the law on healthcare-associated infections
不详
LANCET INFECTIOUS DISEASES, 2008, 8 (10): : 583 - 583

← 1 2 3 4 5 →